{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T06:27:47Z","timestamp":1774506467065,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,9,26]],"date-time":"2014-09-26T00:00:00Z","timestamp":1411689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s00063-014-0416-6","type":"journal-article","created":{"date-parts":[[2014,9,24]],"date-time":"2014-09-24T11:14:18Z","timestamp":1411557258000},"page":"145-149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Hirntoddiagnostik nach Gabe von Propofol oder Sufentanil","Brain death diagnosis after sedation with propofol or sufentanil"],"prefix":"10.1007","volume":"110","author":[{"given":"U.","family":"Walter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Br\u00fcderlein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gloger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Walther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,26]]},"reference":[{"key":"416_CR1","first-page":"A1861","volume":"95","author":"Wissenschaftlicher","year":"1998","unstructured":"Wissenschaftlicher Beirat der Bundes\u00e4rztekammer (1998) Richtlinien zur Feststellung des Hirntodes. Dritte Fortschreibung 1997 mit Erg\u00e4nzungen gem\u00e4\u00df Transplantationsgesetz (TPG). Dtsch \u00c4rztebl 95:A1861\u2013A1868","journal-title":"Dtsch \u00c4rztebl"},{"key":"416_CR2","first-page":"121","volume":"69","author":"F\u00f6rderreuther","year":"2002","unstructured":"F\u00f6rderreuther S, Angstwurm H (2002) Notwendigkeit und Bedeutung toxikologischer Untersuchungen f\u00fcr die Hirntoddiagnostik aus neurologischer Sicht. Toxichem Krimtech 69:121\u2013123","journal-title":"Toxichem Krimtech"},{"key":"416_CR3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1055\/s-0029-1220351","volume":"36","author":"Reimers","year":"2009","unstructured":"Reimers CD, Pulkowski U (2009) Mobiles Konsiliarteam aus Neurologen und Neurochirurgen der Region Nord der Deutschen Stiftung Organtransplantation (Schleswig \u2013 Holstein, Hamburg, Bremen, Niedersachsen). FAQs zur Hirntoddiagnostik: Empfehlungen zur Verfahrensweise. Akt Neurol 36:313\u2013322","journal-title":"Akt Neurol"},{"key":"416_CR4","unstructured":"Walter U, Besser R, Ferbert A et al (2014) Empfehlungen der Deutschen Gesellschaft f\u00fcr Klinische Neurophysiologie und funktionelle Bildgebung zur Bestimmung des Hirntodes. http:\/\/www.dgkn.de\/fileadmin\/user_upload\/pdfs\/Richtlinien\/RL_DGKN_Verschiedenes_Bestimmung_Hirntod_2014.pdf. Zugegriffen: 30. Juni 2014"},{"key":"416_CR5","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1055\/s-0032-1307467","volume":"47","author":"Moskopp","year":"2012","unstructured":"Moskopp D (2012) Hirntoddiagnostik. Anasthesiol Intensivmed Notfallmed Schmerzther 47:176\u2013185","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"416_CR6","first-page":"227","volume":"76","author":"Hallbach","year":"2009","unstructured":"Hallbach J, Meyer L von, Maurer HH (2009) Empfehlungen des Arbeitskreises Klinische Toxikologie der GTFCh f\u00fcr die toxikologische Analytik im Rahmen der Hirntod-Feststellung. Toxichem Krimtech 76:227\u2013231","journal-title":"Toxichem Krimtech"},{"key":"416_CR7","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJM200104193441606","volume":"344","author":"Wijdicks","year":"2001","unstructured":"Wijdicks EFM (2001) Current concepts: the diagnosis of brain death. N Engl J Med 344:1215\u20131221","journal-title":"N Engl J Med"},{"key":"416_CR8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00063-012-0146-6","volume":"108","author":"Harrer","year":"2013","unstructured":"Harrer JU, Nedelmann M, Eyding J et al (2013) Sonographische Diagnostik in der neurologischen Notfall- und Intensivmedizin. Med Klin Intensivmed Notfmed 108:131\u2013138","journal-title":"Med Klin Intensivmed Notfmed"},{"key":"416_CR9","doi-asserted-by":"crossref","first-page":"R136","DOI":"10.1186\/cc11441","volume":"16","author":"Schulz","year":"2012","unstructured":"Schulz M, Iwersen-Bergmann S, Andresen H et al (2012) Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics. Crit Care 16:R136","journal-title":"Crit Care"},{"key":"416_CR10","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1055\/s-0033-1349000","volume":"48","author":"Bushuven","year":"2013","unstructured":"Bushuven S, Heise D (2013) Propofol up2date. Teil 1: Geschichte und pharmakologische Charakteristika. Anasthesiol Intensivmed Notfallmed Schmerzther 48:378\u2013385","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"416_CR11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00000542-198809000-00011","volume":"69","author":"Shafer","year":"1988","unstructured":"Shafer A, Doze VA, Shafer SL et al (1988) Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia. Anesthesiology 69:348\u2013356","journal-title":"Anesthesiology"},{"key":"416_CR12","first-page":"1000","volume":"77","author":"Wess\u00e9n","year":"1993","unstructured":"Wess\u00e9n A, Persson PM, Nilsson A et al (1993) Concentration-effect relationships of propofol after total intravenous anesthesia. Anesth Analg 77:1000\u20131007","journal-title":"Anesth Analg"},{"key":"416_CR13","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1097\/00000542-199906000-00003","volume":"90","author":"Schnider","year":"1999","unstructured":"Schnider TW, Minto CF, Shafer SL et al (1999) The influence of age on propofol pharmacodynamics. Anesthesiology 90:1502\u20131516","journal-title":"Anesthesiology"},{"key":"416_CR14","unstructured":"Fachinformation Propofol 2\u2009%. http:\/\/generika.cc\/dt\/generika\/fachinfo\/reg\/54199. Zugegriffen: 30. Juni 2014"},{"key":"416_CR15","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/bja\/68.5.486","volume":"68","author":"Bailie","year":"1992","unstructured":"Bailie GR, Cockshott ID, Douglas EJ et al (1992) Pharmacokinetics of propofol during and after long term continouos infusion for maintenance of sedation in ICU patients. Br J Anaesth 68:486\u2013491","journal-title":"Br J Anaesth"},{"key":"416_CR16","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00000542-199008000-00004","volume":"73","author":"Albanese","year":"1990","unstructured":"Albanese J, Martin C, Lacarelle B et al (1990) Pharmacokinetics of long-term propofol infusion used for sedation in ICU patients. Anesthesiology 73:214\u2013217","journal-title":"Anesthesiology"},{"key":"416_CR17","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/01.ftd.0000158079.53577.46","volume":"27","author":"Peters","year":"2005","unstructured":"Peters FT, Jung J, Kraemer T et al (2005) Fast, simple, and validated gas chromatographic-mass spectrometric assay for quantification of drugs relevant to diagnosis of brain death in human blood plasma samples. Ther Drug Monit 27:334\u2013344","journal-title":"Ther Drug Monit"},{"key":"416_CR18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12272-013-0265-5","volume":"37","author":"Han","year":"2014","unstructured":"Han E (2014) A study of analytical methods for the determination of propofol in blood. Arch Pharm Res 37:157\u2013167","journal-title":"Arch Pharm Res"},{"key":"416_CR19","unstructured":"Larsen R (2006) An\u00e4sthesie. Urban & Fischer, M\u00fcnchen"},{"key":"416_CR20","unstructured":"Baselt RC (2008) Disposition of toxic drugs and chemicals in man. Biomedical Publications, Foster City"},{"key":"416_CR21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0379-0738(01)00483-2","volume":"122","author":"Winek","year":"2001","unstructured":"Winek CL, Wahba WW, Winek CL Jr et al (2001) Drug and chemical blood-level data 2001. Forensic Sci Int 122:107\u2013123","journal-title":"Forensic Sci Int"},{"key":"416_CR22","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/00000542-199403000-00025","volume":"80","author":"Woestenborghs","year":"1994","unstructured":"Woestenborghs RJ, Timmerman PM, Cornelissen ML et al (1994) Assay methods for sufentanil in plasma. Radioimmunoassay versus gas chromatography-mass spectrometry. Anesthesiology 80:666\u2013670","journal-title":"Anesthesiology"},{"key":"416_CR23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.forsciint.2009.01.013","volume":"186","author":"Gergov","year":"2009","unstructured":"Gergov M, Nokua P, Vouri E et al (2009) Simultaneous screening and quantification of 25 opioid drugs in post-mortem blood and urine by liquid chromatograhy-tandem mass spectrometry. Forensic Sci Int 186:36\u201343","journal-title":"Forensic Sci Int"},{"key":"416_CR24","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1002\/jssc.201000330","volume":"33","author":"Cooreman","year":"2010","unstructured":"Cooreman S, Deprez C, Martens F et al (2010) A comprehensive LC-MS-based quantitative analysis of fentanyl-like drugs in plasma and urine. J Sep Sci 33:2654\u20132662","journal-title":"J Sep Sci"},{"key":"416_CR25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jpba.2012.03.050","volume":"66","author":"Saari","year":"2012","unstructured":"Saari TI, Fechner J, Ihmsen H et al (2012) Determination of total and unbound sufentanil in human plasma by ultrafiltration and LC-MS\/MS: application to clinical pharmacokinetic study. J Pharm Biomed Anal 66:306\u2013313","journal-title":"J Pharm Biomed Anal"},{"key":"416_CR26","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/00000542-198903000-00011","volume":"70","author":"Hudson","year":"1989","unstructured":"Hudson RJ, Bergstrom RG, Thomson IR et al (1989) Pharmacokinetics of sufentanil in patients undergoing abdominal aortic surgery. Anesthesiology 70:426\u2013431","journal-title":"Anesthesiology"},{"key":"416_CR27","unstructured":"Fachinformation Sufenta. http:\/\/generika.cc\/dt\/generika\/fachinfo\/reg\/52413. Zugegriffen: 30. Juni 2014"},{"key":"416_CR28","first-page":"495","volume":"Res","author":"Manfio","year":"2013","unstructured":"Manfio JL, Santos LM, Carmona MJ et al (2013) Pharmacokinetic assessment of sufentanil in cardiac surgery. Drug Res (Stuttg) 63:495\u2013500","journal-title":"Drug"},{"key":"416_CR29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2165\/00044011-199918050-00005","volume":"18","author":"Brusset","year":"1999","unstructured":"Brusset A, Levron JC, Olivier P et al (1999) Comparative Pharmacokinetic Study of Fentanyl and Sufentanil after Single High-Bolus Doses. Clin Drug Invest 18:377\u2013389","journal-title":"Clin Drug Invest"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-014-0416-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00063-014-0416-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-014-0416-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T22:29:04Z","timestamp":1558564144000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00063-014-0416-6"}},"subtitle":["Empfehlungen zum Umgang mit toxikologischer Analytik","Recommendations for the usage of toxicological analytics"],"short-title":[],"issued":{"date-parts":[[2014,9,26]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["416"],"URL":"https:\/\/doi.org\/10.1007\/s00063-014-0416-6","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,26]]}}}